Drug Type Small molecule drug |
Synonyms LEO 35299 |
Target |
Action antagonists, modulators |
Mechanism CXCR4 antagonists(C-X-C motif chemokine receptor 4 antagonists), Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Phase 1 | France | 07 May 2012 | |
Psoriasis vulgaris | Phase 1 | France | 01 Apr 2012 |